Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Unaudited Financial Results for the quarter and half year ended on September 30, 2025 and matters related thereto and other business matters, if any.